Hour24 News
Sophisticated and simple
-
Strategic Licensing Move Targets Ophthalmic Inflammation Treatments Formosa Pharmaceuticals, a Taiwan-based bioscience company, has announced a landmark licensing agreement with Samil Pharmaceuticals, Co., Ltd. that…
